Cerenome is trading 10.1% up at $1.80 in pre-market on October 8, with no clear company-specific announcement identified to explain the move. - Shares closed at $1.64 on October 7. - The latest release listed on Cerenome’s investor-relations page is the October 6 launch announcement for two CNSide molecular profiling tests, available starting October 12. That prior announcement does not establish a reason for the pre-market gain.